Andrea S. Blevins Primeau, PhD, MBA

Andrea S. Blevins Primeau, PhD, MBA, is a freelance medical writer and editor based in central Pennsylvania. She enjoys writing about a variety of topics including oncology, cardiovascular disease, and autoimmune disorders. Previously, she conducted research investigating the role of pharmacogenetics on the efficacy of oncologic therapies.

All articles by Andrea S. Blevins Primeau, PhD, MBA

This fact sheet reviews the current guidelines for coronavirus disease 2019 (COVID-19) vaccination in patients with cancer.

Practice Management

Fact Sheet: COVID-19 Vaccine Considerations for Patients With Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

May 26, 2021

This fact sheet reviews the current guidelines for coronavirus disease 2019 (COVID-19) vaccination in patients with cancer.

Needs-assessment survey identifies knowledge gaps of novel therapeutics for CACS

Palliative Care Considered Beneficial, Though Infrequently Used in Lung Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

March 24, 2021

A team of international investigators deployed a survey to understand the needs of patients with EGFR-positive lung cancer community.

As post-transplant medications are used to reduce the body’s immune reaction to a foreign organ, the

Prolonged Postoperative Opioid Use Noted in Early-Stage Breast Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

June 19, 2020

Patients with early-stage breast cancer who undergo mastectomy with or without reconstruction are at risk of prolonged opioid use.

Next post in Cancer Pain

Genetic research

Genetic Polymorphisms: Understanding Their Relationship With Cancer Pain